Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

77 results about "Chronic fatigue" patented technology

Therapy for enteric infections

ActiveUS8772242B2Antibacterial agentsBiocideNervous systemDiverticulitis
There is disclosed herein a composition for treating gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhea, chronic idiopathic nausea, IBD-associated constipation and diarrhea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, Parkinsons disease, MS, Alzheimers Disease, Motor Neurone Disease or autism, the composition comprising: (i) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or (ii) at least one anti-clostridial agent selected from the above combined with an opioid blocking agent. There is also disclosed herein a method of treating various gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers diarrhea, chronic idiopathic nausea, IBD-associated constipation and diarrhea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, Parkinsons disease, MS, Alzheimers Disease, Motor Neurone Disease or autism, the method comprising administering orally, via enema or by suppository: (i) a composition of the invention; (ii) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or (iii) at least one anti-clostridial agent selected from the above and an opioid blocking agent to a patient in need of such treatment.
Owner:BORODY THOMAS JULIUS

Enzymatic fermented black tea beverage and preparation method thereof

InactiveCN106173025ASolve the production processSolve the problem that product standards are not easy to controlTea extractionPreservativeBlack tea
The invention discloses an enzymatic fermented black tea beverage and a preparation method thereof. The enzymatic fermented black tea beverage comprises the following raw materials in percentage by weight: 1 to 30% of enzymatic fermented black tea juice, 1 to 10% of tea concentrated juice, 0.01 to 10% of a sweetener, 0.01 to 0.1% of a preservative, 0.05 to 0.1% of edible essence and the balance of water, and the sum of the raw materials is 100%. The enzymatic fermented black tea beverage prepared by the invention has rich nutriments and good taste, is nutritional and healthy, not only solves the problems of difficult control on the traditional fermented black tea production process and product standards and quality instability, but also greatly shortens the fermentation production cycle of fermented black tea and solves the problem of large energy consumption of the fermented black tea. The prepared fermented black tea beverage disclosed by the invention has the characteristics of clear and bright color, pure tea fragrance, mellow taste, moderate sweetness and mild sourness, and further has the healthcare functions of promoting appetite, invigorating the stomach, helping digestion, increasing appetite and the like, and the characteristics of enhancing the human immunity, regulating the body acid-base balance, improving chronic fatigue and enhancing physical constitution, thereby being superior to the traditional fermented black tea beverage.
Owner:NINGBO XINUOYA MARINE BIOTECH CO LTD

Health care wine and preparation method thereof

ActiveCN106929363ASolve the problem of short shelf life and unstable qualityEffective treatmentAntinoxious agentsAlcoholic beverage preparationSpleenChronic fatigue
The invention relates to a health care wine and a preparation method thereof. The wine contains 20-60 parts of cistanche, 20-40 parts of herba epimedii, 10-30 parts of mulberry, 10-30 parts of Chinese wolfberry, 10-30 parts of cornus officinalis, 10-30 parts of jujube, 1-2 parts of cervus elaphus linnaeus, and 45-65 parts of rock sugar. Soaking, filter, blending, wine storage, filling, capping and other processes are carried out to prepare the health care wine. The wine provided by the invention well solves the problems of short preservation period in traditional health care products, by preparing the materials into wine, the drug efficacy is improved, several traditional Chinese medicines in a reasonable ratio are made into the health care wine with the multiple health care effects of benefiting qi and tonifying deficiency, moistening five internal organs, harmonizing blood vessels, benefiting essence qi, supplementing essence, strengthening muscles and bones, invigorating spleen and stomach, nourishing yin and reinforcing yang, etc. The wine base is soaked, water is added to allocate the alcohol content, and rock sugar is added to blend the sugar degree, thus obtaining the product. Sensory tests show that the product is clear and transparent, has good taste, and has extensive adaptability in treatment of chronic fatigue syndromes and the health care field.
Owner:URUMQI SHENGMING HELI HIGH TECH

Cordyceps militaris tea bag and preparation method thereof

The invention relates to a cordyceps militaris tea bag and a preparation method thereof, and belongs to the field of tea bags. Cordyceps militaris, licorice roots, Chinese wolfberry fruits, chrysanthemums, lemons, dried lily bulbs, wild jujubes, pears, dandelions, lotus leaves, mint, honeysuckle flowers, dried orange peel, haws and fructus momordicae are adopted. The preparation method comprises the following steps of performing superspeed freeze-drying by a freeze-drying technique for 1-3 seconds, and performing direct proportioning, so that people can drink the brewed cordyceps militaris tea bag; or loading dry ultrafine powder in an earthen jar, performing uniform stirring with loess at places where the cordyceps militaris grows until a paste is obtained, sealing the opening of the jar, performing natural fermentation and alcoholization, placing the treated earthen jar in natural ventilation environment, absorbing the essence of the sun and the moon in the universe, after one year, performing microwave sterilization, performing simultaneous drying, removing dampness, performing filtering, and performing loading into bags, so that the tea bag can be drunk. People drink the tea, so that the effects of preventing people from suffering from diseases and benefitting vigour are achieved, various diseases caused by chronic fatigue syndromes are relieved, and the efficacy of delaying ageing, prolonging life can be achieved.
Owner:LIAONING FUYUDA AGRI SCI & TECH

Application of n-3PUFA phosphatide in products for alleviating chronic fatigue syndromes

The invention provides an application of n-3PUFA phosphatide in products for alleviating chronic fatigue syndromes. Specifically, EPA phosphatide is extracted from trepang, DHA phosphatide is extracted from squid eggs, components of the EPA phosphatide are prepared, components of the DHA phosphatide are separated, and finally weariness resistance test verification is performed on the components of the EPA phosphatide and the components of the DHA phosphatide. According to the application disclosed by the invention, the EPA phosphatide is prepared by using the trepang as a raw material, the DHA phosphatide is prepared by using the squid eggs as a raw material, then component separation and transformation are performed, and the purity of prepared PC, the purity of the prepared PE, the purity of the prepared PS and the purity of the prepared PI are all 90% or above. According to the application disclosed by the invention, animal experiments verify that the components of the prepared EPA phosphatide and the components of the prepared DHA phosphatide can greatly prolong the running time of mice in a fatigue apparatus, namely that the EPA phosphatide and the DHA phosphatide can both obviously improve the fatigue tolerance of mice suffering from chronic fatigue syndromes under moderate intensity, and the EPA phosphatide and the DHA phosphatide can effectively prevent, alleviate or treat the chronic fatigue syndromes.
Owner:OCEAN UNIV OF CHINA

Conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation and production method thereof

The invention relates to the technical field of the traditional Chinese medicine and in particular relates to a conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation for treating chronic fatigue and climacteric syndromes, and a production method of the preparation. The conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation is prepared from such raw materials as conic gymnadenia tuber, sealwort, radix polygonati officinalis, polygonum multiflorum and fructus choerospondiatis. The conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation and the conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation have the advantage that all the medicinal materials are combined to take effect comprehensively so that the preparation is capable of strengthening the body of a patient, reliving fatigue, improving sleeping, enhancing memory ability, adjusting internal secretion and improving the immunity of the organism, has a remarkable curative effect on the chronic fatigue and climacteric syndromes of the patient, and is quick in taking effect and exact in curative effect without toxic and side effects; besides, the production method is capable of guaranteeing the curative effect of the conic gymnadenia tuber-sealwort-radix polygonati officinalis preparation and is simple and easy to operate and low in production cost; and the obtained preparation is convenient to carry and take.
Owner:YUANHE PHARMA CO LTD

Degradable ceramic filled porous ultra-short implant and preparation method thereof

ActiveCN110742705AImproved equivalent elastic modulusAvoid damageDental implantsStress shieldingBone growth
The invention discloses a degradable ceramic filled porous ultra-short implant which comprises a neck portion; a body portion is connected to the lower side of the neck portion and is formed by an outer body and an inner body; the outer body is of a mutually communicating porous structure; the porous structure is filled with degradable bone cement; the inner body is a solid dense portion and is provided with inside threads; the inside threads are in matching connection with a base station; the outer body is externally provided with outside threads; and porous thread ceramic bodies are filled between the adjacent outside threads. By adopting the degradable ceramic filled porous ultra-short implant disclosed by the invention, the equivalent elastic modulus of the ultrashort implant is well improved, and the phenomena of stress shielding and chronic fatigue are reduced; by filling the degradable bone cement, the integrity of the structure during implantation of the implant can be ensured,the success rate of implantation is increased, the implantation efficiency is improved, and tissue damages are reduced; and meanwhile, by filling the porous thread ceramic bodies between the adjacentoutside threads, degradable ceramics can be degraded after implantation, bone growth is induced, the degradable bone cement is degraded, the porous structure appears, and cell growth and body fluid exchange are facilitated.
Owner:XI AN JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products